SEC CIK 1921051
Bertels Mark E.
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CRVLview stock → | 2,918 | 2026-09-30 |
Position History — CRVL
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CRVL
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-30 | Grant / award | 9 | $70.82 | 2,918 |
| 2026-07-29 | Option exercise (derivative) | 750 | $62.25 | 0 |
| 2026-07-29 | Tax withholding | 33 | $62.25 | 2,909 |
| 2026-07-29 | Tax withholding | 634 | $62.25 | 2,942 |
| 2026-07-29 | Option exercise | 750 | $52.65 | 3,576 |
| 2026-04-22 | Option exercise (derivative) | 1,050 | $57.40 | 0 |
| 2026-04-22 | Tax withholding | 94 | $57.40 | 2,826 |
| 2026-04-22 | Tax withholding | 736 | $56.76 | 2,920 |
| 2026-04-22 | Option exercise | 1,050 | $39.83 | 3,656 |
| 2026-03-31 | Grant / award | 12 | $51.92 | 2,606 |
| 2026-03-04 | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2025-11-19 | Option exercise (derivative) | 1,200 | $0.00 | 0 |
| 2025-11-19 | Open-market sale | 1,200 | $72.35 | 2,594 |
| 2025-11-19 | Option exercise | 1,200 | $34.44 | 3,794 |
| 2025-11-06 | Grant / award (derivative) | 4,000 | $0.00 | 4,000 |
| 2025-09-30 | Grant / award | 8 | $73.55 | 2,594 |
| 2025-08-19 | Option exercise (derivative) | 900 | $0.00 | 0 |
| 2025-08-19 | Option exercise | 900 | $29.23 | 3,486 |
| 2025-08-19 | Open-market sale | 900 | $89.17 | 2,586 |
| 2025-05-27 | Option exercise (derivative) | 900 | $0.00 | 0 |
| 2025-05-27 | Option exercise | 900 | $26.50 | 3,486 |
| 2025-05-27 | Open-market sale | 900 | $113.34 | 2,586 |
| 2025-05-15 | Grant / award (derivative) | 2,000 | $0.00 | 2,000 |
| 2025-03-31 | Grant / award | 6 | $106.37 | 2,586 |
| 2025-01-14 | Grant / award (derivative) | 2,500 | $0.00 | 2,500 |
| 2024-12-05 | Option exercise (derivative) | 350 | $0.00 | 0 |
| 2024-12-05 | Option exercise | 350 | $52.69 | 1,210 |
| 2024-12-05 | Open-market sale | 350 | $357.35 | 860 |
| 2024-09-30 | Grant / award | 2 | $310.55 | 860 |
| 2024-08-12 | Option exercise (derivative) | 300 | $0.00 | 0 |
| 2024-08-12 | Open-market sale | 300 | $299.80 | 858 |
| 2024-08-12 | Option exercise | 300 | $88.22 | 1,158 |
| 2024-06-10 | Option exercise (derivative) | 200 | $0.00 | 0 |
| 2024-06-10 | Option exercise | 200 | $87.49 | 1,058 |
| 2024-06-10 | Open-market sale | 200 | $231.14 | 858 |
| 2024-05-16 | Grant / award (derivative) | 400 | $0.00 | 400 |
| 2024-03-28 | Grant / award | 2 | $249.81 | 858 |
| 2023-11-02 | Grant / award (derivative) | 3,500 | $0.00 | 3,500 |
| 2023-09-29 | Grant / award | 3 | $186.82 | 856 |
| 2023-08-10 | Grant / award (derivative) | 500 | $0.00 | 500 |
| 2023-08-04 | Option exercise (derivative) | 250 | $0.00 | 0 |
| 2023-08-04 | Open-market sale | 250 | $215.00 | 853 |
| 2023-08-04 | Option exercise | 250 | $59.32 | 1,103 |
| 2023-06-06 | Option exercise (derivative) | 500 | $0.00 | 0 |
| 2023-06-06 | Open-market sale | 500 | $205.00 | 853 |
| 2023-06-06 | Option exercise | 500 | $57.35 | 1,353 |
| 2023-03-31 | Grant / award | 3 | $180.77 | 853 |
| 2023-02-07 | Option exercise (derivative) | 1,250 | $0.00 | 0 |
| 2023-02-07 | Open-market sale | 1,250 | $185.00 | 850 |
| 2023-02-07 | Option exercise | 1,250 | $49.40 | 2,100 |
| 2022-11-15 | Option exercise (derivative) | 750 | $153.00 | 0 |
| 2022-11-15 | Open-market sale | 750 | $153.00 | 850 |
| 2022-11-15 | Option exercise | 750 | $53.40 | 1,600 |
| 2022-11-03 | Grant / award (derivative) | 4,000 | $0.00 | 4,000 |
| 2022-09-30 | Grant / award | 5 | $131.51 | 850 |
| 2022-08-15 | Option exercise (derivative) | 450 | $0.00 | 0 |
| 2022-08-15 | Open-market sale | 450 | $165.00 | 845 |
| 2022-08-15 | Option exercise | 450 | $57.75 | 1,295 |
| 2022-08-04 | Grant / award (derivative) | 750 | $0.00 | 750 |
| 2022-05-12 | Grant / award (derivative) | 5,250 | $0.00 | 5,250 |
| 2022-04-01 | — | — | — | 845 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.